Article

Retaine now available in multi-dose, preservative-free bottle

OcuSOFT’s Retaine HPMC lubricant eye drops will now be available in a patented multi-dose, preservative-free delivery system.

 

Rosenberg, TX-OcuSOFT’s Retaine HPMC lubricant eye drops will now be available in a patented multi-dose, preservative-free delivery system.

The new delivery system for the eye drops-a preservative-free hyporomellose ophthalmic solution (0.3%) that provides immediate relief to soothe dry, irritated eyes by resembling natural tears-utilizes a proprietary airless pump system that prevents harmful bacteria from entering the bottle and contaminating the solution.

“(The eye drops) remains the gold standard for patients with more demanding dry eye conditions,” said Stacy Foster, executive vice president of OcuSOFT. “However, for patients with less severe conditions, and where budget concerns exist, (the eye drops) with its multi-dose, preservative-free pump dispenser is ideal.

“A measured release 10 ml bottle contains 300 drops offer the benefit of preservative-free dosing without unit-of-use container cost,” Foster added.

The new system was also presented during SECO last week, and will again be shown during Vision Expo East next week in New York City.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.